Profil
Scott Lauder worked as VP-Process Sciences & Clinical Manufacturing at Merrimack Pharmaceuticals, Inc. from 2013 to 2016.
He then worked as Chief Technology Officer at Gemini Therapeutics, Inc. from 2016 to 2021.
Lauder holds a doctorate degree from Northwestern University and an undergraduate degree from the University of Manitoba.
Anciens postes connus de Scott Lauder
| Sociétés | Poste | Fin |
|---|---|---|
| GEMI THER | Directeur Technique/Scientifique/R&D | 17/09/2021 |
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2016 |
Formation de Scott Lauder
| University of Manitoba | Undergraduate Degree |
| Northwestern University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
